Natco Pharma has informed that a meeting of the Board of Directors of the Company will be held on August 12, 2015, to consider various options of rising of funds for one of the subsidiaries Timecap Overseas, Mauritius to be used for investment in Natcofarma Do Brasil Ltda, Brasil, Unaudited financial Results for the quarter ended June 30, 2015 (Q1), Convening of 32nd Annual General Meeting for the financial year 2014-15 and to issue the notice of postal ballot and e-voting to shareholders for approving the Scheme of Amalgamation of Natco Organics into the Company and related matters. Further, the ‘Trading Window’ for dealing in the securities of the Company will be closed from August 04, 2015 to August 14, 2015.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1872.40 |
| Dr. Reddys Lab | 1279.70 |
| Cipla | 1304.70 |
| Zydus Lifesciences | 956.65 |
| Lupin | 2245.65 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: